Surfacide México | Líderes en desinfección UV-C

What Surfacide México | Líderes en desinfección UV-C does

Surfacide México (legal name Surfacide de México S. de R. L. de C. V.) is the Mexican regional operating entity of the US-based Surfacide group, distributing and supporting the Helios UV-C triple-emitter disinfection system for healthcare facilities and other institutions in Mexico. Founded in 2021 and headquartered in Azcapotzalco, Mexico City with five employees, the company runs a direct enterprise field-sales motion targeting hospitals, dental practices, rehabilitation centers, hospitality venues, entertainment and sports facilities, and government sites. The Mexican entity is led by Israel Rodríguez (Director General México), Marco Guerrero (Director Comercial), and Ian Ríos (Gerente de Operaciones México), and participates in Mexican industry forums including Medical Expo, ANHP Congress, and Expo Med.

The core product is the Helios UV-C system, a hardware platform that uses 254nm UV-C germicidal light through a patented triple-emitter configuration to achieve 99.9999% (6-log) microbial reduction on non-porous surfaces within a 2.14-meter radius per emitter. Towers rotate 360 degrees, integrate motion sensors with vibration and infrared detection for safety, and transmit cycle data to a cloud-based portal for administrator monitoring. The system is FDA-authorized (November 2023) and certified under ISO 13485:2016, BSI 8628:2022, CE, ETL, and CSA standards, with the parent company holding 37 international patents and 20+ peer-reviewed scientific publications supporting clinical claims.

Surfacide México generates revenue through three streams: one-time hardware sales of Helios towers, recurring subscription service tiers (HELIOS PRO at 230 disinfection cycles per month, HELIOS PLUS at 450 cycles with a dedicated specialist operator, and HELIOS ULTRA at 1,200 cycles with three operators), and professional services including staff training and on-site specialist operation. Pricing is quote-based and not publicly disclosed. The company also pursues strategic alliances with infection-control bodies such as IUVA, SHEA, Leapfrog Group, AMEIN, Centro Médico ABC, and Hospitales Sin Infecciones to embed its technology into Mexican healthcare quality and patient-safety programs.

Name

Surfacide México | Líderes en desinfección UV-C

Legal name

Surfacide de México S. de R. L. de C. V.

Website

https://surfacidemexico.com

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

1–10 employees

Short description

Surfacide México distributes and supports the Helios UV-C triple-emitter disinfection system for healthcare facilities, hospitality, and public-sector institutions in Mexico, selling hardware alongside recurring subscription tiers that bundle specialist operators and staff training.

Ownership category

akta.pro rank

Headquarters

HQ city

Mexico City

HQ country

Mexico

HQ region

Latin America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Operations

Revenue model

1. Helios UV-C System Sales: Sale of hardware systems including the Helios UV-C disinfection towers with multiple emitters, sensors, and cloud connectivity capabilities.
2. Subscription Service Programs: Monthly subscription plans (HELIOS PRO, PLUS, ULTRA) providing specified numbers of disinfection cycles per month with varying levels of support including training, specialist operators, and preferential pricing on additional disinfections.
3. Professional Services: Specialist UV disinfection operator services included in higher-tier plans, plus training services for client staff.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels7 records

Core offering

Surfacide México designs, distributes, and services the Helios UV-C disinfection system — a triple-emitter hardware tower that uses 254nm germicidal light to achieve 99.9999% (6-log) microbial reduction on non-porous surfaces within a 2.14-meter radius per emitter. The company also sells recurring monthly disinfection subscription programs (HELIOS PRO, PLUS, ULTRA) that bundle cycles, staff training, and dedicated specialist operators for healthcare and public-sector clients in Mexico.

Product overview

Surfacide offers the Helios UV-C triple-emitter disinfection system as its core product, a hardware-based UV-C technology platform for healthcare environments that achieves 99.9999% microbial reduction. The system is complemented by three subscription service tiers: Helios PRO (230 cycles/month with training), Helios PLUS (450 cycles/month with dedicated operator), and Helios ULTRA (1,200 cycles/month with three operators for full hospital coverage). Together, the product family enables healthcare facilities to implement UV-C disinfection programs from on-demand single-area needs to comprehensive, institution-wide disinfection coverage.

Differentiator

Problem solved

Functional benefit

Products and services

• Helios UV-C Disinfection System

Quantifiable outcome

• 99.9999% microbial reduction (6-log reduction)
• +4 more outcomes

Named customers6 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Nine partnerships are on record, tiered core and minor.

• International Association of Ultraviolet (IUVA)coreStrategic or Co-development PartnerIUVA promotes ultraviolet technology in science, engineering and applications, focusing on public health and environmental protection. They are established as leaders in education, industry, research and public policy globally. Surfacide maintains commitment to quality and science dissemination through alliances with organizations like IUVA.
• Society for Healthcare Epidemiology of America (SHEA)coreStrategic or Co-development PartnerSHEA focuses on improving public health by establishing infection prevention measures and supporting responsible antibiotic stewardship. Represents experts in epidemiology, infection prevention and antimicrobials globally. Surfacide participates in their initiatives for infection control advancement.
• Leapfrog GroupcoreStrategic or Co-development PartnerLeapfrog acts as the voice of healthcare leaders in the United States, aiming to achieve significant advances in safety, quality and accessibility. Establishes standards and publishes hospital ratings on care quality and services. Surfacide aligns with their quality and safety standards.
• Medical ExpominorGTM or Marketing PartnerRecognized national medical device exhibition in Mexico. Beyond presenting medical technology, addresses critical health problems through specialized forums such as the 'Challenge of Hospital Infections' forum focused on Healthcare-Associated Infections (HAAS).
• ANHP (Asociación Nacional de Hospitales Privados)minorGTM or Marketing PartnerANHP Congress gathered experts discussing medical innovation, resource management and care humanization. Topics included cooperation between public and private sectors for healthcare. Surfacide participates in their congress to engage with private hospital leaders.
• Sociedad Mexicana de Ingeniería BiomédicaminorGTM or Marketing PartnerSurfacide participated in Expo Med 2023 medical exhibition, invited by the Mexican Society of Biomedical Engineering, with the conference 'Preventive Disinfection, A New Paradigm in Infection Control' to present their hospital disinfection methodology.
• Hospitales Sin InfeccionescoreStrategic or Co-development PartnerProject 'Hospitals Without Infections' aims to generate awareness about HAAS and promote preventive measures. Seeks to involve all responsible actors including patients, families, general society, health authorities, companies, health professionals and specialist associations.
• Centro Médico ABCcoreStrategic or Co-development PartnerCentro Médico ABC organizes the International Congress on Quality and Patient Safety, bringing together more than 500 professionals with national and international speakers addressing topics including infection control and environmental care. Surfacide participates in this healthcare quality forum.
• Asociación Mexicana para el Estudio de las Infecciones Nosocomiales (AMEIN)coreStrategic or Co-development PartnerAMEIN promotes research, prevention and control of HAAS in Mexico, as well as evidence-based policy development, education and professional training. Their congresses promote collaboration among health professionals with knowledge exchange and strategies on infections.

Scale indicators6 records

Recent moves5 records

Expansion highlights5 records

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/surfacidemexico
• LinkedInlinkedin.com/company/surfacide-mexico
• Instagraminstagram.com/surfacidemx

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Surfacide México | Líderes en desinfección UV-C